BackgroundHypothalamic obesity (HO) is a major concern in patients treated for craniopharyngioma (CP). The influence of degree of resection on development of HO, event-free survival (EFS), and neuroendocrine sequelae is an issue of debate.ProcedureA retrospective cohortconsisting of all CP patients treated between 2002 and 2012 in two university hospitals was identified. Multivariable logistic regression was used to study the associations between preoperative BMI, age at diagnosis, tumor volume, performed surgical resection, and presence of HO at follow-up.ResultsThirty-five patients (21 children and 14 adults) were included. Median follow-up time was 35.6 months (4.1-114.7). Four patients were obese at diagnosis. HO was present in 19 (54.3...
An adamantinous craniopharyngioma (CP) is rare benign pituitary tumour often growing invasively and ...
Craniopharyngioma (CP) is a histologically benign tumor with high mortality and morbidity. Although ...
Obesity is a common complication after craniopharyngioma therapy, occurring in up to 75% of survivor...
BackgroundHypothalamic obesity (HO) is a major concern in patients treated for craniopharyngioma (CP...
BackgroundHypothalamic obesity (HO) is a major concern in patients treated for craniopharyngioma (CP...
Background: Hypothalamic obesity (HO) is a major concern in patients treated for craniopharyngioma (...
Hypothalamic obesity is an major concern in children treated for craniopharyngioma. Not only the cra...
ContextHypothalamic obesity (HO) is a severe complication following craniopharyngioma, but studies r...
An epidemic of pediatric obesity has occurred across the world in recent years. There are subgroups ...
The development of hypothalamic obesity (HO) following craniopharyngioma (CP) and other suprasellar ...
An epidemic of pediatric obesity has occurred across the world in recent years. There are subgroups ...
Obesity and hypopituitarism are major side effects of craniopharyngiomas. Awareness of the presence ...
Craniopharyngioma and its treatment lead to weight gain and pituitary hormone deficiencies. This stu...
Craniopharyngiomas (CP) are epithelial neoplasms generally found in the area of the pitu-itary and h...
Background/objectives: Hypothalamic obesity (HO) occurs in 50% of patients with the pituitary tumor ...
An adamantinous craniopharyngioma (CP) is rare benign pituitary tumour often growing invasively and ...
Craniopharyngioma (CP) is a histologically benign tumor with high mortality and morbidity. Although ...
Obesity is a common complication after craniopharyngioma therapy, occurring in up to 75% of survivor...
BackgroundHypothalamic obesity (HO) is a major concern in patients treated for craniopharyngioma (CP...
BackgroundHypothalamic obesity (HO) is a major concern in patients treated for craniopharyngioma (CP...
Background: Hypothalamic obesity (HO) is a major concern in patients treated for craniopharyngioma (...
Hypothalamic obesity is an major concern in children treated for craniopharyngioma. Not only the cra...
ContextHypothalamic obesity (HO) is a severe complication following craniopharyngioma, but studies r...
An epidemic of pediatric obesity has occurred across the world in recent years. There are subgroups ...
The development of hypothalamic obesity (HO) following craniopharyngioma (CP) and other suprasellar ...
An epidemic of pediatric obesity has occurred across the world in recent years. There are subgroups ...
Obesity and hypopituitarism are major side effects of craniopharyngiomas. Awareness of the presence ...
Craniopharyngioma and its treatment lead to weight gain and pituitary hormone deficiencies. This stu...
Craniopharyngiomas (CP) are epithelial neoplasms generally found in the area of the pitu-itary and h...
Background/objectives: Hypothalamic obesity (HO) occurs in 50% of patients with the pituitary tumor ...
An adamantinous craniopharyngioma (CP) is rare benign pituitary tumour often growing invasively and ...
Craniopharyngioma (CP) is a histologically benign tumor with high mortality and morbidity. Although ...
Obesity is a common complication after craniopharyngioma therapy, occurring in up to 75% of survivor...